-+ 0.00%
-+ 0.00%
-+ 0.00%

US FDA ADVISERS VOTE 7-2, WITH ONE ABSTENTION, THAT BENEFITS OF GRAIL'S GALLERI TEST OUTWEIGH RISKS FOR PROPOSED USE

Reuters·09/23/2026 21:31:50

Please log in to view news